Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Frontier, acquisition and group update

26 Nov 2021 07:00

RNS Number : 6241T
Science Group PLC
26 November 2021
Β 

Β 

Β 

Β 

26 November 2021

Β 

Science Group plc

Β 

Frontier Update, Acquisition

Β 

and

Β 

Group Trading Update

Β 

Β 

Frontier Smart Technologies ("Frontier") was acquired by Science Group in 2019. Following a successful turnaround and integration, Frontier is now a very profitable business, contributing to the Group at a similar level to the Group's Services operations. As a result, and subsequent to a review of the Frontier strategy early in the year, Science Group has been investing in the Frontier business during 2021.

Β 

The recent UK Digital Radio and Audio Review reaffirmed that radio continues to be a strong trusted medium delivering significant public value and highlighted the success of DAB. This UK experience is believed by Frontier to be replicated in other geographic markets. However like all technology markets, the product category is evolving and one of the growth opportunities identified in the strategy review undertaken in early 2021 was to develop the SmartRadio segment. SmartRadio combines DAB/DAB+, FM and Internet Radio providing access to tens of thousands of radio stations worldwide. In addition, the product category is also attracting diverse demographics as (i) audio streaming services such as Spotify, Deezer and Amazon Music become mainstream, and (ii) significant growth is now being seen in "spoken word" services, such as podcasts and audiobooks.

Β 

In progressing the Frontier strategy, the Board has now completed the acquisition of Magic Systech Inc ("Magic"), a Taiwan-based company which specialises in Internet Radio technology. The acquisition enhances the Frontier proposition including a lower production cost technology architecture. For the year ended 31 December 2020, unaudited results for Magic reported revenue of US$2 million and a profit before tax of US$0.4 million. Magic will be integrated into Frontier but the Magic Systech brand will be retained. Consideration for the acquisition was US$4 million, paid in cash, although at completion Magic held cash of $1.9 million, giving a net valuation of $2.1 million for the business. The acquisition of Magic is the second significant investment in Frontier resulting from the 2021 strategy review, following on from the $6 million technology royalty buyout in July.

Β 

Trading Update

Β 

While the Frontier acquisition has been highly successful and has made a significant contribution to Science Group, trading in all divisions continues positively. As a result, the Group remains in line or slightly ahead of the upgraded guidance provided on 11 October 2021. In summary, the Board of Science Group anticipate reporting another strong operating performance for 2021.

Β 

Following the Science Group strategic investment in TP Group in August and the subsequent restructuring of that Board, the new strategy for TP Group was announced on 1 November 2021. As reported by TP Group, this strategy focuses on the UK-based Defence and Aerospace operations which contribute approximately 70% of TP Group revenue and a greater proportion of the profit contribution. The relationship between Science Group and TP Group has developed constructively in recent weeks and the Science Group Board remains positive in relation to the long term merits of the investment.

Β 

End

Β 

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)

Nick Adams, Alex Price

Tel: +44 (0) 20 7710 7600

Liberum Capital Limited (Joint Broker)

Neil Patel, Cameron Duncan

Tel: +44 (0) 20 3100 2000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCLELFLFFLBFBE
Date   Source Headline
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSAudited results for year ended 31 December 2023
19th Mar 20247:00 amRNSNotice of Preliminary Results
26th Jan 20247:00 amRNSRule 19.6(c) confirmation of post-offer intentions
22nd Dec 20237:00 amRNSRule 19.6(b) update to post-offer intentions
18th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202312:00 pmRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20233:57 pmRNSTreasury Stock
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in own shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20237:01 amRNSTransaction in Own Shares
16th Oct 20237:00 amRNSTreasury & EBT Shares Issued
13th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
2nd Oct 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSHolding(s) in Company
2nd Aug 202312:34 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSTotal Voting Rights
28th Jul 20237:00 amRNSTreasury shares issued & PDMR dealing
27th Jul 20237:00 amRNSTreasury shares issued
24th Jul 20237:00 amRNSInterim results for 6 months ended 30 June 2023
18th Jul 20231:35 pmRNSNotice of Interim Results
13th Jul 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.